[1]
|
Ellinger, J., Müller, S.C. and Dietrich, D. (2015) Epigenetic Biomarkers in the Blood of Patients with Urological Malig-nancies. Expert Review of Molecular Diagnostics, 15, 505-516. https://doi.org/10.1586/14737159.2015.1019477
|
[2]
|
Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Inci-dence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9. https://doi.org/10.1016/j.jncc.2022.02.002
|
[3]
|
董德鑫, 李汉忠, 纪志刚, 等. 常见泌尿生殖系统肿瘤的病因学分析及预防[J]. 基础医学与临床, 2019, 39(6): 904-907. https://doi.org/10.16352/j.issn.1001-6325.2019.06.027
|
[4]
|
胡永伟, 白永颖, 张靖华. 乳腺癌患者血浆凝血参数的变化及临床意义[J]. 医学信息, 2023, 36(4): 113-117.
|
[5]
|
Tikhomirova, I., Petrochenko, E., Malysheva, Y., et al. (2016) Interrelation of Blood Coagulation and Hemorheology in Cancer. Clinical Hemorheology and Microcirculation, 64, 635-644. https://doi.org/10.3233/CH-168037
|
[6]
|
周合冰, 刘复强, 闫树旭, 等. 恶性疾病患者凝血纤溶分子标志物的研究[J]. 中国卫生检验杂志, 2008(2): 302-305.
|
[7]
|
Tas, F., Kilic, L., Serilmez, M., et al. (2013) Clinical and Prognostic Significance of Coagulation Assays in Lung Cancer. Respiratory Medicine, 107, 451-457. https://doi.org/10.1016/j.rmed.2012.11.007
|
[8]
|
Khorana, A.A., Mackman, N., Falanga, A., et al. (2022) Can-cer-Associated Venous Thromboembolism. Nature Reviews. Disease Primers, 8, Article No. 11. https://doi.org/10.1038/s41572-022-00336-y
|
[9]
|
Kacimi, S.E.O., Moeinafshar, A., Haghighi, S.S., et al. (2022) Venous Thromboembolism in Cancer and Cancer Immunotherapy. Critical Reviews in Oncology/Hematology, 178, Arti-cle ID: 103782.
https://doi.org/10.1016/j.critrevonc.2022.103782
|
[10]
|
Izuegbuna, O.O., Agodirin, O.S., Olawumi, H.O., et al. (2021) Plasma D-Dimer and Fibrinogen Levels Correlates with Tumor Size and Disease Progression in Nigerian Breast Cancer Patients. Cancer Investigation, 39, 597-606.
https://doi.org/10.1080/07357907.2021.1909059
|
[11]
|
Zhang, L., Ye, J., Luo, Q., et al. (2020) Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT). Cancer Management and Research, 12, 5373-5384. https://doi.org/10.2147/CMAR.S246695
|
[12]
|
石磊, 孟桂芳. 凝血四项指标与肺癌患者临床分期的相关性[J]. 航空航天医学杂志, 2023, 34(2): 163-166.
|
[13]
|
王瑜, 王珊珊. 肿瘤标志物及凝血功能检测对宫颈癌分期诊断价值探讨[J]. 社区医学杂志, 2023, 21(3): 146-150.
https://doi.org/10.19790/j.cnki.JCM.2023.03.08
|
[14]
|
Ahlbrecht, J., Dickmann, B., Ay, C., et al. (2012) Tumor Grade Is Associated with Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology, 30, 3870-3875. https://doi.org/10.1200/JCO.2011.40.1810
|
[15]
|
Falanga, A., Schieppati, F. and Russo, D. (2015) Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer. Seminars in Thrombosis and Hemo-stasis, 41, 756-764.
https://doi.org/10.1055/s-0035-1564040
|
[16]
|
Falanga, A., Russo, L., Milesi, V., et al. (2017) Mechanisms and Risk Factors of Thrombosis in Cancer. Critical Reviews in Oncology/Hematology, 118, 79-83. https://doi.org/10.1016/j.critrevonc.2017.08.003
|
[17]
|
Berny-Lang, M.A., Aslan, J.E., Tormoen, G.W., et al. (2011) Promotion of Experimental Thrombus Formation by the Procoagulant Activity of Breast Cancer Cells. Physical Biology, 8, Article ID: 015014.
https://doi.org/10.1088/1478-3975/8/1/015014
|
[18]
|
Hong, S.K., Ko, D.W., Park, J., et al. (2010) Alteration of An-tithrombin III and D-Dimer Levels in Clinically Localized Prostate Cancer. Korean Journal of Urology, 51, 25-29. https://doi.org/10.4111/kju.2010.51.1.25
|
[19]
|
Chen, X., Ji, H., Wang, J., et al. (2020) Prognostic Value of the Preoperative Plasma D-Dimer Levels in Patients with Upper Tract Urothelial Carcinoma in a Retrospective Cohort Study. OncoTargets and Therapy, 13, 5047-5055.
https://doi.org/10.2147/OTT.S254514
|
[20]
|
Çalişkan, S. and Sungur, M. (2017) Fibrinogen and D-Dimer Levels in Prostate Cancer: Preliminary Results. Prostate International, 5, 110-112. https://doi.org/10.1016/j.prnil.2017.05.001
|
[21]
|
Polterauer, S., Seebacher, V., Hefler-Frischmuth, K., et al. (2009) Fibrinogen Plasma Levels Are an Independent Prognostic Parameter in Patients with Cervical Cancer. American Journal of Obstetrics and Gynecology, 200, 647.e1-7.
https://doi.org/10.1016/j.ajog.2009.01.008
|
[22]
|
Sheng, L., Luo, M., Sun, X., et al. (2013) Serum Fibrinogen Is an Independent Prognostic Factor in Operable Nonsmall Cell Lung Cancer. International Journal of Cancer, 133, 2720-2725. https://doi.org/10.1002/ijc.28284
|
[23]
|
Wang, F.M. and Xing, N.Z. (2021) Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Un-derwent Transrectal Ultrasound-Guided Prostate Biopsy. Disease Markers, 2021, Article ID: 8899994. https://doi.org/10.1155/2021/8899994
|
[24]
|
Liu, R., Zhou, X., Zou, L., et al. (2019) Clinicopathological and Prog-nostic Significance of Preoperative Plasma Fibrinogen Level in Patients with Upper Urinary Tract Urothelial Carcinoma: A Retrospective Tumor Marker Prognostic Study. International Journal of Surgery, 65, 88-93. https://doi.org/10.1016/j.ijsu.2019.03.022
|
[25]
|
Sasaki, T. and Onishi, T. (2015) Pretherapeutic Plasma Fibrinogen Level Is an Independent Survival Predictor in Renal Cell Carcinoma. Oncology Research and Treatment, 38, 374-378. https://doi.org/10.1159/000435896
|
[26]
|
Yang, S., Guan, H., Wang, S., et al. (2020) Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients after Radical Cystectomy. Cancer Management and Research, 12, 9303-9314. https://doi.org/10.2147/CMAR.S269244
|
[27]
|
Gay, L.J. and Felding-Habermann, B. (2011) Contribution of Plate-lets to Tumour Metastasis. Nature Reviews Cancer, 11, 123-134. https://doi.org/10.1038/nrc3004
|
[28]
|
Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribution to Cancer Progression. Journal of Thrombosis and Haemosta-sis: JTH, 9, 237-249. https://doi.org/10.1111/j.1538-7836.2010.04131.x
|
[29]
|
Ishikawa, S., Miyashita, T., Inokuchi, M., et al. (2016) Platelets Surrounding Primary Tumor Cells Are Related to Chemoresistance. Oncology Reports, 36, 787-794. https://doi.org/10.3892/or.2016.4898
|
[30]
|
Shimodaira, K., Nakashima, J., Nakagami, Y., et al. (2020) Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urology Journal, 17, 36-41.
|
[31]
|
Moschini, M., Suardi, N., Pellucchi, F., et al. (2014) Impact of Preoperative Thrombocytosis on Pathological Outcomes and Survival in Patients Treated with Radical Cystectomy for Bladder Carcinoma. Anticancer Research, 34, 3225-3230.
|
[32]
|
Ha, Y.S., Chung, J.W., Chun, S.Y., et al. (2017) Impact of Preoperative Thrombocytosis on Prognosis after Surgical Treatment in Pathological T1 and T2 Renal Cell Carcinoma: Results of a Multi-Institutional Comprehensive Study. Oncotarget, 8, 64449-64458. https://doi.org/10.18632/oncotarget.16136
|
[33]
|
Smith, C.J., Dorsey, T.H., Tang, W., et al. (2017) Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recur-rence in African-American Men. Cancer Epidemiology, Biomarkers & Prevention, 26, 845-853.
https://doi.org/10.1158/1055-9965.EPI-16-1027
|
[34]
|
Dell’Atti, L. (2014) Correlation between Prolonged Use of Aspirin and Prognostic Risk in Prostate Cancer. Tumori, 100, 486-490. https://doi.org/10.1177/1660.18156
|
[35]
|
Pastore, A.L., Palleschi, G., Fuschi, A., et al. (2015) Can Daily Intake of Aspirin and/or Statins Influence the Behavior of Non-Muscle Invasive Bladder Cancer? A Retrospective Study on a Co-hort of Patients Undergoing Transurethral Bladder Resection. BMC Cancer, 15, Article No. 120. https://doi.org/10.1186/s12885-015-1152-x
|
[36]
|
Park, J.C., Pratz, C.F., Tesfaye, A., et al. (2015) The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 13, 32-38. https://doi.org/10.1016/j.clgc.2014.04.008
|